nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—Psoriasis flare-up—Ramipril—type 1 diabetes mellitus	0.035	0.0564	CcSEcCtD
Citalopram—Depressed mood—Ramipril—type 1 diabetes mellitus	0.0143	0.023	CcSEcCtD
Citalopram—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.0143	0.023	CcSEcCtD
Citalopram—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0127	0.0204	CcSEcCtD
Citalopram—Balance disorder—Ramipril—type 1 diabetes mellitus	0.0117	0.0189	CcSEcCtD
Citalopram—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.011	0.0177	CcSEcCtD
Citalopram—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.011	0.0177	CcSEcCtD
Citalopram—Psoriasis—Ramipril—type 1 diabetes mellitus	0.0102	0.0164	CcSEcCtD
Citalopram—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00919	0.0148	CcSEcCtD
Citalopram—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00919	0.0148	CcSEcCtD
Citalopram—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.00794	0.0128	CcSEcCtD
Citalopram—Ageusia—Ramipril—type 1 diabetes mellitus	0.00788	0.0127	CcSEcCtD
Citalopram—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0077	0.0124	CcSEcCtD
Citalopram—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00737	0.0119	CcSEcCtD
Citalopram—Glossitis—Ramipril—type 1 diabetes mellitus	0.00693	0.0112	CcSEcCtD
Citalopram—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00688	0.0111	CcSEcCtD
Citalopram—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00679	0.011	CcSEcCtD
Citalopram—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.0062	0.01	CcSEcCtD
Citalopram—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00599	0.00968	CcSEcCtD
Citalopram—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.0058	0.00937	CcSEcCtD
Citalopram—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00577	0.00932	CcSEcCtD
Citalopram—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00571	0.00922	CcSEcCtD
Citalopram—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00571	0.00922	CcSEcCtD
Citalopram—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00535	0.00864	CcSEcCtD
Citalopram—Polyuria—Ramipril—type 1 diabetes mellitus	0.00528	0.00852	CcSEcCtD
Citalopram—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00523	0.00844	CcSEcCtD
Citalopram—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00518	0.00836	CcSEcCtD
Citalopram—Deafness—Ramipril—type 1 diabetes mellitus	0.00518	0.00836	CcSEcCtD
Citalopram—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00516	0.00833	CcSEcCtD
Citalopram—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00513	0.00829	CcSEcCtD
Citalopram—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00509	0.00821	CcSEcCtD
Citalopram—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00502	0.0081	CcSEcCtD
Citalopram—Libido decreased—Ramipril—type 1 diabetes mellitus	0.005	0.00807	CcSEcCtD
Citalopram—Amnesia—Ramipril—type 1 diabetes mellitus	0.00493	0.00796	CcSEcCtD
Citalopram—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00489	0.00789	CcSEcCtD
Citalopram—Purpura—Ramipril—type 1 diabetes mellitus	0.00481	0.00776	CcSEcCtD
Citalopram—Arthritis—Ramipril—type 1 diabetes mellitus	0.00477	0.0077	CcSEcCtD
Citalopram—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00475	0.00767	CcSEcCtD
Citalopram—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00475	0.00767	CcSEcCtD
Citalopram—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00473	0.00763	CcSEcCtD
Citalopram—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00465	0.00751	CcSEcCtD
Citalopram—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0046	0.00742	CcSEcCtD
Citalopram—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00428	0.00691	CcSEcCtD
Citalopram—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00423	0.00683	CcSEcCtD
Citalopram—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00423	0.00683	CcSEcCtD
Citalopram—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00419	0.00676	CcSEcCtD
Citalopram—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00417	0.00674	CcSEcCtD
Citalopram—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00417	0.00674	CcSEcCtD
Citalopram—Gastritis—Ramipril—type 1 diabetes mellitus	0.0041	0.00662	CcSEcCtD
Citalopram—Asthma—Ramipril—type 1 diabetes mellitus	0.00401	0.00647	CcSEcCtD
Citalopram—Influenza—Ramipril—type 1 diabetes mellitus	0.00401	0.00647	CcSEcCtD
Citalopram—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00401	0.00647	CcSEcCtD
Citalopram—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00397	0.0064	CcSEcCtD
Citalopram—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00394	0.00636	CcSEcCtD
Citalopram—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00393	0.00634	CcSEcCtD
Citalopram—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.0039	0.0063	CcSEcCtD
Citalopram—Sweating increased—Ramipril—type 1 diabetes mellitus	0.0039	0.0063	CcSEcCtD
Citalopram—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00385	0.00622	CcSEcCtD
Citalopram—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00384	0.0062	CcSEcCtD
Citalopram—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.0038	0.00614	CcSEcCtD
Citalopram—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00372	0.00601	CcSEcCtD
Citalopram—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00369	0.00596	CcSEcCtD
Citalopram—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00366	0.0059	CcSEcCtD
Citalopram—Weight increased—Ramipril—type 1 diabetes mellitus	0.00365	0.00588	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00354	0.00572	CcSEcCtD
Citalopram—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00352	0.00568	CcSEcCtD
Citalopram—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.0035	0.00565	CcSEcCtD
Citalopram—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.0035	0.00565	CcSEcCtD
Citalopram—Jaundice—Ramipril—type 1 diabetes mellitus	0.00348	0.00562	CcSEcCtD
Citalopram—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00348	0.00562	CcSEcCtD
Citalopram—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00347	0.0056	CcSEcCtD
Citalopram—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00347	0.0056	CcSEcCtD
Citalopram—Sweating—Ramipril—type 1 diabetes mellitus	0.00342	0.00553	CcSEcCtD
Citalopram—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00338	0.00545	CcSEcCtD
Citalopram—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00337	0.00544	CcSEcCtD
Citalopram—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00335	0.00541	CcSEcCtD
Citalopram—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00333	0.00538	CcSEcCtD
Citalopram—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00321	0.00518	CcSEcCtD
Citalopram—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00316	0.0051	CcSEcCtD
Citalopram—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00315	0.00509	CcSEcCtD
Citalopram—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00309	0.00499	CcSEcCtD
Citalopram—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00303	0.00489	CcSEcCtD
Citalopram—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00299	0.00483	CcSEcCtD
Citalopram—Flushing—Ramipril—type 1 diabetes mellitus	0.00298	0.0048	CcSEcCtD
Citalopram—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.0029	0.00467	CcSEcCtD
Citalopram—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00289	0.00466	CcSEcCtD
Citalopram—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00286	0.00462	CcSEcCtD
Citalopram—Alopecia—Ramipril—type 1 diabetes mellitus	0.00283	0.00457	CcSEcCtD
Citalopram—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00281	0.00453	CcSEcCtD
Citalopram—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00279	0.00451	CcSEcCtD
Citalopram—Erythema—Ramipril—type 1 diabetes mellitus	0.00279	0.00451	CcSEcCtD
Citalopram—Tension—Ramipril—type 1 diabetes mellitus	0.00274	0.00442	CcSEcCtD
Citalopram—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00273	0.00441	CcSEcCtD
Citalopram—Nervousness—Ramipril—type 1 diabetes mellitus	0.00271	0.00438	CcSEcCtD
Citalopram—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00268	0.00433	CcSEcCtD
Citalopram—Tremor—Ramipril—type 1 diabetes mellitus	0.00262	0.00422	CcSEcCtD
Citalopram—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00259	0.00418	CcSEcCtD
Citalopram—Agitation—Ramipril—type 1 diabetes mellitus	0.00257	0.00414	CcSEcCtD
Citalopram—Angioedema—Ramipril—type 1 diabetes mellitus	0.00255	0.00412	CcSEcCtD
Citalopram—Malaise—Ramipril—type 1 diabetes mellitus	0.00252	0.00406	CcSEcCtD
Citalopram—Vertigo—Ramipril—type 1 diabetes mellitus	0.00251	0.00405	CcSEcCtD
Citalopram—Syncope—Ramipril—type 1 diabetes mellitus	0.0025	0.00404	CcSEcCtD
Citalopram—Leukopenia—Ramipril—type 1 diabetes mellitus	0.0025	0.00403	CcSEcCtD
Citalopram—Palpitations—Ramipril—type 1 diabetes mellitus	0.00247	0.00398	CcSEcCtD
Citalopram—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00245	0.00396	CcSEcCtD
Citalopram—Cough—Ramipril—type 1 diabetes mellitus	0.00244	0.00393	CcSEcCtD
Citalopram—Convulsion—Ramipril—type 1 diabetes mellitus	0.00242	0.0039	CcSEcCtD
Citalopram—Chest pain—Ramipril—type 1 diabetes mellitus	0.00238	0.00384	CcSEcCtD
Citalopram—Myalgia—Ramipril—type 1 diabetes mellitus	0.00238	0.00384	CcSEcCtD
Citalopram—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00238	0.00384	CcSEcCtD
Citalopram—Anxiety—Ramipril—type 1 diabetes mellitus	0.00237	0.00382	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00236	0.00381	CcSEcCtD
Citalopram—Discomfort—Ramipril—type 1 diabetes mellitus	0.00235	0.00379	CcSEcCtD
Citalopram—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00232	0.00375	CcSEcCtD
Citalopram—Confusional state—Ramipril—type 1 diabetes mellitus	0.0023	0.00371	CcSEcCtD
Citalopram—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00228	0.00368	CcSEcCtD
Citalopram—Oedema—Ramipril—type 1 diabetes mellitus	0.00228	0.00368	CcSEcCtD
Citalopram—Shock—Ramipril—type 1 diabetes mellitus	0.00224	0.00362	CcSEcCtD
Citalopram—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00223	0.00361	CcSEcCtD
Citalopram—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00223	0.0036	CcSEcCtD
Citalopram—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00222	0.00359	CcSEcCtD
Citalopram—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00221	0.00357	CcSEcCtD
Citalopram—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.0022	0.00355	CcSEcCtD
Citalopram—Anorexia—Ramipril—type 1 diabetes mellitus	0.00217	0.00351	CcSEcCtD
Citalopram—Hypotension—Ramipril—type 1 diabetes mellitus	0.00213	0.00344	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00208	0.00335	CcSEcCtD
Citalopram—Insomnia—Ramipril—type 1 diabetes mellitus	0.00206	0.00333	CcSEcCtD
Citalopram—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00205	0.0033	CcSEcCtD
Citalopram—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00203	0.00328	CcSEcCtD
Citalopram—Somnolence—Ramipril—type 1 diabetes mellitus	0.00203	0.00327	CcSEcCtD
Citalopram—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00201	0.00324	CcSEcCtD
Citalopram—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00198	0.0032	CcSEcCtD
Citalopram—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00197	0.00317	CcSEcCtD
Citalopram—Fatigue—Ramipril—type 1 diabetes mellitus	0.00196	0.00317	CcSEcCtD
Citalopram—Constipation—Ramipril—type 1 diabetes mellitus	0.00195	0.00314	CcSEcCtD
Citalopram—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00188	0.00303	CcSEcCtD
Citalopram—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00186	0.00301	CcSEcCtD
Citalopram—Urticaria—Ramipril—type 1 diabetes mellitus	0.00181	0.00292	CcSEcCtD
Citalopram—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.0018	0.00291	CcSEcCtD
Citalopram—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.0018	0.00291	CcSEcCtD
Citalopram—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00168	0.00271	CcSEcCtD
Citalopram—Asthenia—Ramipril—type 1 diabetes mellitus	0.00163	0.00264	CcSEcCtD
Citalopram—Pruritus—Ramipril—type 1 diabetes mellitus	0.00161	0.0026	CcSEcCtD
Citalopram—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00156	0.00252	CcSEcCtD
Citalopram—Dizziness—Ramipril—type 1 diabetes mellitus	0.00151	0.00243	CcSEcCtD
Citalopram—Vomiting—Ramipril—type 1 diabetes mellitus	0.00145	0.00234	CcSEcCtD
Citalopram—Rash—Ramipril—type 1 diabetes mellitus	0.00144	0.00232	CcSEcCtD
Citalopram—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00144	0.00232	CcSEcCtD
Citalopram—Headache—Ramipril—type 1 diabetes mellitus	0.00143	0.0023	CcSEcCtD
Citalopram—Nausea—Ramipril—type 1 diabetes mellitus	0.00135	0.00218	CcSEcCtD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000136	0.000357	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000136	0.000356	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000134	0.000353	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000134	0.000351	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000134	0.000351	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000133	0.00035	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000133	0.000349	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000133	0.000349	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000133	0.000349	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000132	0.000348	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000132	0.000348	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000132	0.000346	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000131	0.000344	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00013	0.000342	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00013	0.000342	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00013	0.000341	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.00013	0.000341	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000129	0.00034	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000129	0.00034	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000129	0.00034	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000129	0.000339	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000127	0.000335	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000127	0.000334	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000127	0.000334	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000127	0.000333	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000126	0.00033	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000125	0.000328	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000124	0.000327	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	0.000124	0.000326	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000124	0.000325	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000122	0.000322	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000122	0.00032	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000121	0.000318	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000121	0.000318	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000119	0.000313	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000118	0.000309	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000117	0.000308	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	0.000116	0.000306	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000116	0.000304	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000116	0.000304	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000114	0.000301	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000114	0.0003	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000112	0.000295	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000112	0.000294	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000112	0.000293	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00011	0.00029	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00011	0.000289	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00011	0.000289	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000109	0.000286	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000108	0.000285	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000108	0.000285	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	0.000108	0.000283	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	0.000107	0.000281	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000107	0.000281	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000106	0.000279	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SST—type 1 diabetes mellitus	0.000106	0.000279	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000106	0.000278	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—HBA1—type 1 diabetes mellitus	0.000106	0.000277	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000105	0.000277	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000105	0.000276	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000105	0.000276	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—APOC3—type 1 diabetes mellitus	0.000105	0.000276	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000105	0.000275	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000105	0.000275	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000104	0.000274	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000104	0.000274	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000103	0.000272	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000103	0.000271	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000103	0.00027	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000103	0.00027	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000102	0.000269	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000101	0.000266	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	0.000101	0.000265	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.0001	0.000264	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.0001	0.000263	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.0001	0.000263	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.88e-05	0.00026	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.85e-05	0.000259	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	9.84e-05	0.000259	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	9.7e-05	0.000255	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	9.56e-05	0.000251	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GCG—type 1 diabetes mellitus	9.46e-05	0.000249	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	9.42e-05	0.000248	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SST—type 1 diabetes mellitus	9.19e-05	0.000242	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	9.16e-05	0.000241	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.15e-05	0.000241	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	9.12e-05	0.00024	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.1e-05	0.000239	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	9.02e-05	0.000237	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	8.99e-05	0.000236	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	8.98e-05	0.000236	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.84e-05	0.000232	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.82e-05	0.000232	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	8.65e-05	0.000227	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	8.44e-05	0.000222	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	8.38e-05	0.00022	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	8.21e-05	0.000216	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GCG—type 1 diabetes mellitus	8.19e-05	0.000215	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	8.17e-05	0.000215	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	8.14e-05	0.000214	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	8.09e-05	0.000213	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.04e-05	0.000211	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.04e-05	0.000211	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.01e-05	0.00021	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	7.98e-05	0.00021	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	7.95e-05	0.000209	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	7.95e-05	0.000209	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	7.95e-05	0.000209	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	7.9e-05	0.000208	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.89e-05	0.000207	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.86e-05	0.000207	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	7.8e-05	0.000205	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	7.75e-05	0.000204	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	7.74e-05	0.000203	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD86—type 1 diabetes mellitus	7.71e-05	0.000203	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.66e-05	0.000201	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.64e-05	0.000201	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.64e-05	0.000201	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.62e-05	0.0002	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.52e-05	0.000198	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.5e-05	0.000197	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	7.49e-05	0.000197	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	7.44e-05	0.000196	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.36e-05	0.000194	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.32e-05	0.000192	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.32e-05	0.000192	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	7.31e-05	0.000192	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	7.09e-05	0.000186	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.96e-05	0.000183	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.95e-05	0.000183	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	6.95e-05	0.000183	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.94e-05	0.000182	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.94e-05	0.000182	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.91e-05	0.000182	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.84e-05	0.00018	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	6.83e-05	0.00018	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	6.81e-05	0.000179	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	6.8e-05	0.000179	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	6.74e-05	0.000177	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.74e-05	0.000177	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.69e-05	0.000176	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	6.68e-05	0.000176	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	6.66e-05	0.000175	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.56e-05	0.000172	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.38e-05	0.000168	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.36e-05	0.000167	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	6.34e-05	0.000167	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.34e-05	0.000167	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	6.33e-05	0.000166	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.32e-05	0.000166	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	6.3e-05	0.000166	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.26e-05	0.000165	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.22e-05	0.000163	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	6.19e-05	0.000163	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	6.18e-05	0.000162	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	6.16e-05	0.000162	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.02e-05	0.000158	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6e-05	0.000158	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.92e-05	0.000156	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.91e-05	0.000155	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.91e-05	0.000155	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.84e-05	0.000153	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	5.82e-05	0.000153	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.82e-05	0.000153	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.81e-05	0.000153	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.79e-05	0.000152	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.78e-05	0.000152	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.73e-05	0.000151	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.71e-05	0.00015	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.69e-05	0.000149	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CD80—type 1 diabetes mellitus	5.62e-05	0.000148	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	5.36e-05	0.000141	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.31e-05	0.00014	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.23e-05	0.000137	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.2e-05	0.000137	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.14e-05	0.000135	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.11e-05	0.000134	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	4.93e-05	0.00013	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	4.93e-05	0.00013	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	4.9e-05	0.000129	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.87e-05	0.000128	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	4.86e-05	0.000128	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	4.86e-05	0.000128	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.78e-05	0.000126	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.78e-05	0.000126	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.75e-05	0.000125	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	4.71e-05	0.000124	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.66e-05	0.000122	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	4.61e-05	0.000121	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	4.6e-05	0.000121	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	4.59e-05	0.000121	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.52e-05	0.000119	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.45e-05	0.000117	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.44e-05	0.000117	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.43e-05	0.000116	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.42e-05	0.000116	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.37e-05	0.000115	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.35e-05	0.000114	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	4.32e-05	0.000113	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	4.23e-05	0.000111	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.18e-05	0.00011	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	4.13e-05	0.000108	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.11e-05	0.000108	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.1e-05	0.000108	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	4.04e-05	0.000106	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.04e-05	0.000106	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.04e-05	0.000106	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.03e-05	0.000106	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.96e-05	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.96e-05	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	3.95e-05	0.000104	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.93e-05	0.000103	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.81e-05	0.0001	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	3.56e-05	9.35e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.47e-05	9.13e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.43e-05	9.01e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.42e-05	9e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.42e-05	8.98e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.41e-05	8.97e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.41e-05	8.95e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.4e-05	8.92e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.36e-05	8.84e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.36e-05	8.83e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.34e-05	8.78e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.32e-05	8.74e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.27e-05	8.6e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	3.26e-05	8.57e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.22e-05	8.47e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.18e-05	8.37e-05	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	3.12e-05	8.2e-05	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.04e-05	8e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.02e-05	7.94e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3e-05	7.88e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.88e-05	7.57e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.87e-05	7.55e-05	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.87e-05	7.54e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.83e-05	7.43e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	2.77e-05	7.28e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.62e-05	6.88e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.61e-05	6.86e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.57e-05	6.75e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.54e-05	6.68e-05	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.43e-05	6.39e-05	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.32e-05	6.1e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.14e-05	5.62e-05	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.01e-05	5.29e-05	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.01e-05	5.27e-05	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.97e-05	5.19e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.96e-05	5.15e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.88e-05	4.93e-05	CbGpPWpGaD
